📑Wednesday read! On behalf of EASL, we are excited to share an article on: "Use of non-invasive diagnostic tools for metabolic dysfunction-associated steatohepatitis: A qualitative exploration of challenges and barriers." Explore the barriers to using non-invasive tests (NITs) for MASLD and find out how we can enhance their utilisation. 🔗Learn more: https://lnkd.in/d2SY-hvc
This is an important project and a great collaboration!
Thank you for sharing! At CTI we recognize the importance of overcoming the challenges and barriers to utilizing these tools. Enhancing their adoption is vital for advancing our field and improving patient outcomes. Looking forward to exploring these insights further and contributing to the progress in hepatology.